Here’s Why Bruker’s (BRKR) Positive Momentum Returned in Q4
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Bruker Corp (BRKR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Orbis Investment Management William B. Gray | 14,906,730 | $702,256,050 | +6% | 2.94% |
| 2. | Sculptor Capital Daniel S. Och | 3,000,000 | $141,330,000 | -3% | 1.46% |
| 3. | Aequim Alternative Investments Franklin Parlamis | 374,000 | $136,438,317 | +25% | 2.7% |
| 4. | Millennium Management Israel Englander | 1,839,587 | $86,662,944 | +223% | 0.04% |
| 5. | D E Shaw D. E. Shaw | 205,000 | $74,807,396 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.36 | 2,608 | $100,042.88 | 38,462,171 | 2025-06-06 | Filing | |
| $47.40 | 500 | $23,697.50 | 3,472 | 2025-03-10 | Filing | |
| $51.23 | 6,937 | $355,382.51 | 38,459,563 | 2025-02-18 | Filing | |
| $50.75 | 13,063 | $662,947.25 | 38,452,626 | 2025-02-18 | Filing | |
| $51.36 | 3,583 | $184,022.88 | 38,439,563 | 2024-11-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $35.44 | 2,000 | $70,880.00 | 128,443 | 2026-03-13 | Filing | |
| $36.94 | 2,000 | $73,880.00 | 128,443 | 2026-02-13 | Filing | |
| $49.20 | 2,000 | $98,400.00 | 128,443 | 2026-01-15 | Filing | |
| $55.00 | 7,000 | $385,000.00 | 128,443 | 2026-01-12 | Filing | |
| $49.25 | 15,337 | $755,347.25 | 128,443 | 2026-01-05 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 35,475 | $1,281,357 | 0.03% | |
| 2. | 17,521 | $644,065 | 0% | |
| 3. | 5,624 | $203,139 | 0.05% | |
| 4. | 3,916 | $141,446 | 0.01% | |
| 5. | 551 | $19,894 | 0% |
News See All
Will Bruker (BRKR) be Able to Rebound?
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap Fund”. A copy of the letter can be downloaded here.
Reasons Why Bruker Corporation (BRKR) Appears So Attractive
On February 13, Jefferies analyst Tycho Peterson reduced the firm’s price target on Bruker Corporation (NASDAQ:BRKR) from $55 to $50.
10 Best Life Sciences Stocks to Buy According to Hedge Funds
Following a difficult start in 2025, the ever-evolving life sciences segment recovered strongly in the latter half of the year.
Bruker Corporation (NASDAQ:BRKR) Q4 2025 Earnings Call Transcript
Operator: Good morning, everyone, and welcome to the Bruker Corporation Fourth Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode.
Guggenheim Raises Price Target for Bruker Corporation (BRKR)
On January 26, Guggenheim analyst Subbu Nambi reiterated her Buy rating on Bruker Corporation (NASDAQ:BRKR).
12 Best Medical Devices Stocks to Invest In According to Hedge Funds
It is challenging to identify segments within the markets that appear to be defensive plays, yet offer innovation potential.
Bruker Corporation (BRKR): A Bull Case Theory
We came across a bullish thesis on Bruker Corporation on r/valueinvesting by TheDynamicMolecule. In this article, we will summarize the bulls’ thesis on BRKR.
Goldman Sachs Initiates Sell Rating On Bruker Corporation (BRKR)
According to The Fly, on December 9, 2025, Goldman Sachs started Bruker Corporation (NASDAQ:BRKR) with a Sell rating and a $40 price objective.
13 Best Nanotechnology Stocks to Buy Now
Nanotechnology is defined by the National Nanotechnology Initiative as the control of matter in the range of 1 to 100 nanometers, where materials have characteristics distinct from those of bulk forms...
Hedge Fund Resource Center